Certara, Inc. - CERT

SEC FilingsOur CERT Tweets

About Gravity Analytica

Recent News

  • 02.12.2026 - Simcyp® Simulator Version 25: Streamline Drug Development with Regulatory-Compliant PBPK
  • 02.12.2026 - EMA Policy 0070 Submission Readiness Checklist
  • 02.12.2026 - The “Easy Button” for PK/PD TFLs and Reports (TFL Studio & AI PK Reports)
  • 02.12.2026 - Certara IQ™ Global Roadshow
  • 02.11.2026 - Certara IQ™ Workshop
  • 02.11.2026 - Anti-PD-(L)1 Antibodies: Insights From QSP-Based Meta-Analysis
  • 02.11.2026 - Pediatric Drug Development: From “Wild West” to Model-Informed Confidence
  • 02.10.2026 - QSP in Inflammatory Bowel Disease (IBD): From Biomarkers to Clinical Endpoints, with Virtual Patients
  • 02.06.2026 - Certara Introduces CRF Creator Module in Pinnacle 21® Enterprise for Faster Clinical Study Start-Up in Drug Development
  • 02.05.2026 - Why Many Global Drugs Never Reach Japan

Recent Filings